MGC Diagnostics Corporation Reports 2013 Third Quarter Operating Results

Published: Aug 30, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAINT PAUL, Minn., Aug. 29, 2013 -- /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the third quarter ended July 31, 2013.

Third Quarter Highlights:

Robust third quarter revenue of $7.9 million, a 15% increase over the fiscal 2012 third quarter. Sequential quarterly revenue growth of 4.8% from the fiscal 2013 second quarter

Help employers find you! Check out all the jobs and post your resume.

Back to news